148 related articles for article (PubMed ID: 25682969)
1. TGF-β Regulates Survivin to Affect Cell Cycle and the Expression of EGFR and MMP9 in Glioblastoma.
Chen W; Zhong X; Wei Y; Liu Y; Yi Q; Zhang G; He L; Chen F; Liu Y; Luo J
Mol Neurobiol; 2016 Apr; 53(3):1648-1653. PubMed ID: 25682969
[TBL] [Abstract][Full Text] [Related]
2. SDF-1/CXCR4 Axis Regulates Cell Cycle Progression and Epithelial-Mesenchymal Transition via Up-regulation of Survivin in Glioblastoma.
Liao A; Shi R; Jiang Y; Tian S; Li P; Song F; Qu Y; Li J; Yun H; Yang X
Mol Neurobiol; 2016 Jan; 53(1):210-215. PubMed ID: 25421212
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-564 is downregulated in glioblastoma and inhibited proliferation and invasion of glioblastoma cells by targeting TGF-β1.
Jiang C; Shen F; Du J; Hu Z; Li X; Su J; Wang X; Huang X
Oncotarget; 2016 Aug; 7(35):56200-56208. PubMed ID: 27621042
[TBL] [Abstract][Full Text] [Related]
4. Survivin expression is regulated by coexpression of human epidermal growth factor receptor 2 and epidermal growth factor receptor via phosphatidylinositol 3-kinase/AKT signaling pathway in breast cancer cells.
Asanuma H; Torigoe T; Kamiguchi K; Hirohashi Y; Ohmura T; Hirata K; Sato M; Sato N
Cancer Res; 2005 Dec; 65(23):11018-25. PubMed ID: 16322251
[TBL] [Abstract][Full Text] [Related]
5. SDF-1/CXCR4 signaling up-regulates survivin to regulate human sacral chondrosarcoma cell cycle and epithelial-mesenchymal transition via ERK and PI3K/AKT pathway.
Yang P; Wang G; Huo H; Li Q; Zhao Y; Liu Y
Med Oncol; 2015 Jan; 32(1):377. PubMed ID: 25428386
[TBL] [Abstract][Full Text] [Related]
6. Involvement of smad2 and Erk/Akt cascade in TGF-β1-induced apoptosis in human gingival epithelial cells.
Yoshimoto T; Fujita T; Kajiya M; Matsuda S; Ouhara K; Shiba H; Kurihara H
Cytokine; 2015 Sep; 75(1):165-73. PubMed ID: 25882870
[TBL] [Abstract][Full Text] [Related]
7. Wogonin induces apoptosis and down-regulates survivin in human breast cancer MCF-7 cells by modulating PI3K-AKT pathway.
Huang KF; Zhang GD; Huang YQ; Diao Y
Int Immunopharmacol; 2012 Feb; 12(2):334-41. PubMed ID: 22182776
[TBL] [Abstract][Full Text] [Related]
8. Sox2 targets cyclinE, p27 and survivin to regulate androgen-independent human prostate cancer cell proliferation and apoptosis.
Lin F; Lin P; Zhao D; Chen Y; Xiao L; Qin W; Li D; Chen H; Zhao B; Zou H; Zheng X; Yu X
Cell Prolif; 2012 Jun; 45(3):207-16. PubMed ID: 22469032
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of EGFR/PI3K/AKT cell survival pathway promotes TSA's effect on cell death and migration in human ovarian cancer cells.
Zhou C; Qiu L; Sun Y; Healey S; Wanebo H; Kouttab N; Di W; Yan B; Wan Y
Int J Oncol; 2006 Jul; 29(1):269-78. PubMed ID: 16773209
[TBL] [Abstract][Full Text] [Related]
10. Phosphatidylinositol 3-kinase/Akt pathway is involved in transforming growth factor-beta1-induced phenotypic modulation of 10T1/2 cells to smooth muscle cells.
Lien SC; Usami S; Chien S; Chiu JJ
Cell Signal; 2006 Aug; 18(8):1270-8. PubMed ID: 16310342
[TBL] [Abstract][Full Text] [Related]
11. Oncogenic Ras blocks transforming growth factor-beta-induced cell-cycle arrest by degradation of p27 through a MEK/Erk/SKP2-dependent pathway.
Schepers H; Wierenga AT; Eggen BJ; Vellenga E
Exp Hematol; 2005 Jul; 33(7):747-57. PubMed ID: 15963850
[TBL] [Abstract][Full Text] [Related]
12. Effects of epidermal growth factor receptor and phosphatase and tensin homologue gene expression on the inhibition of U87MG glioblastoma cell proliferation induced by protein kinase inhibitors.
Xing WJ; Zou Y; Han QL; Dong YC; Deng ZL; Lv XH; Jiang T; Ren H
Clin Exp Pharmacol Physiol; 2013 Jan; 40(1):13-21. PubMed ID: 23110505
[TBL] [Abstract][Full Text] [Related]
13. TGF-β1 regulates cell fate during epithelial-mesenchymal transition by upregulating survivin.
Lee J; Choi JH; Joo CK
Cell Death Dis; 2013 Jul; 4(7):e714. PubMed ID: 23828577
[TBL] [Abstract][Full Text] [Related]
14. Signal transduction of MEK/ERK and PI3K/Akt activation by hypoxia/reoxygenation in renal epithelial cells.
Kwon DS; Kwon CH; Kim JH; Woo JS; Jung JS; Kim YK
Eur J Cell Biol; 2006 Nov; 85(11):1189-99. PubMed ID: 16860436
[TBL] [Abstract][Full Text] [Related]
15. Rapamycin-mediated mTOR inhibition attenuates survivin and sensitizes glioblastoma cells to radiation therapy.
Anandharaj A; Cinghu S; Park WY
Acta Biochim Biophys Sin (Shanghai); 2011 Apr; 43(4):292-300. PubMed ID: 21367753
[TBL] [Abstract][Full Text] [Related]
16. Both mitogen-activated protein kinase (MAPK)/extracellular-signal-regulated kinases (ERK) 1/2 and phosphatidylinositide-3-OH kinase (PI3K)/Akt pathways regulate activation of E-twenty-six (ETS)-like transcription factor 1 (Elk-1) in U138 glioblastoma cells.
Mut M; Lule S; Demir O; Kurnaz IA; Vural I
Int J Biochem Cell Biol; 2012 Feb; 44(2):302-10. PubMed ID: 22085529
[TBL] [Abstract][Full Text] [Related]
17. Differential intracellular signalling induced by TGF-beta in rat adult hepatocytes and hepatoma cells: implications in liver carcinogenesis.
Caja L; Ortiz C; Bertran E; Murillo MM; Miró-Obradors MJ; Palacios E; Fabregat I
Cell Signal; 2007 Apr; 19(4):683-94. PubMed ID: 17055226
[TBL] [Abstract][Full Text] [Related]
18. Blocking the PI3K/AKT and MEK/ERK signaling pathways can overcome gefitinib-resistance in non-small cell lung cancer cell lines.
Li H; Schmid-Bindert G; Wang D; Zhao Y; Yang X; Su B; Zhou C
Adv Med Sci; 2011; 56(2):275-84. PubMed ID: 22037177
[TBL] [Abstract][Full Text] [Related]
19. Shikonin Inhibits the Migration and Invasion of Human Glioblastoma Cells by Targeting Phosphorylated β-Catenin and Phosphorylated PI3K/Akt: A Potential Mechanism for the Anti-Glioma Efficacy of a Traditional Chinese Herbal Medicine.
Zhang FY; Hu Y; Que ZY; Wang P; Liu YH; Wang ZH; Xue YX
Int J Mol Sci; 2015 Oct; 16(10):23823-48. PubMed ID: 26473829
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor-β1 induces EMT by the transactivation of epidermal growth factor signaling through HA/CD44 in lung and breast cancer cells.
Li L; Qi L; Liang Z; Song W; Liu Y; Wang Y; Sun B; Zhang B; Cao W
Int J Mol Med; 2015 Jul; 36(1):113-22. PubMed ID: 26005723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]